» Articles » PMID: 27669154

Informatics-Based Discovery of Disease-Associated Immune Profiles

Overview
Journal PLoS One
Date 2016 Sep 27
PMID 27669154
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in flow and mass cytometry are enabling ultra-high resolution immune profiling in mice and humans on an unprecedented scale. However, the resulting high-content datasets challenge traditional views of cytometry data, which are both limited in scope and biased by pre-existing hypotheses. Computational solutions are now emerging (e.g., Citrus, AutoGate, SPADE) that automate cell gating or enable visualization of relative subset abundance within healthy versus diseased mice or humans. Yet these tools require significant computational fluency and fail to show quantitative relationships between discrete immune phenotypes and continuous disease variables. Here we describe a simple informatics platform that uses hierarchical clustering and nearest neighbor algorithms to associate manually gated immune phenotypes with clinical or pre-clinical disease endpoints of interest in a rapid and unbiased manner. Using this approach, we identify discrete immune profiles that correspond with either weight loss or histologic colitis in a T cell transfer model of inflammatory bowel disease (IBD), and show distinct nodes of immune dysregulation in the IBDs, Crohn's disease and ulcerative colitis. This streamlined informatics approach for cytometry data analysis leverages publicly available software, can be applied to manually or computationally gated cytometry data, is suitable for any clinical or pre-clinical setting, and embraces ultra-high content flow and mass cytometry as a discovery engine.

References
1.
Van Raemdonck K, Van den Steen P, Liekens S, Van Damme J, Struyf S . CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. 2014; 26(3):311-27. DOI: 10.1016/j.cytogfr.2014.11.009. View

2.
Ostanin D, Bao J, Koboziev I, Gray L, Robinson-Jackson S, Kosloski-Davidson M . T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol. 2008; 296(2):G135-46. PMC: 2643911. DOI: 10.1152/ajpgi.90462.2008. View

3.
Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

4.
Esensten J, Lee M, Glimcher L, Bluestone J . T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J Immunol. 2009; 183(1):75-82. PMC: 2732575. DOI: 10.4049/jimmunol.0804154. View

5.
Hueber W, Sands B, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins P . Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012; 61(12):1693-700. PMC: 4902107. DOI: 10.1136/gutjnl-2011-301668. View